C FIN INT INV (00721) announces interim results with a net loss of HK$3.703 million, a year-on-year profit turning into a loss.

19:47 26/02/2026

China Financial International (00721) announced its interim results for the six months ending December 31, 2025, with a net loss of 3.703 million Hong Kong dollars, a year-on-year turnaround from profit to loss. The loss was mainly due to administrative expenses increasing from approximately HK$2.78 million in the same period last year to approximately HK$6.228 million in the current period.

C FIN INT INV (00721) released its interim performance for the six months ending December 31, 2025, with a net loss of HK$3,703,000, turning from profit to loss compared to the same period last year. The loss was mainly due to an increase in operating expenses from approximately HK$2,780,000 in the same period last year to approximately HK$6,228,000 in the current period.

CHAMPION TECH (00092) announces an interim loss of HKD 27.836 million attributable to owners, representing a year-on-year increase of 28.83%.

CHINA HEALTH (00673) issued 48 million shares on February 26th.

Contemporary Amperex Technology (03750): "26CATLK1" will be listed on the Shenzhen Stock Exchange starting from February 27th.

CHAMPION TECH (00092) announces an interim loss of HKD 27.836 million attributable to owners, representing a year-on-year increase of 28.83%.

CHINA HEALTH (00673) issued 48 million shares on February 26th.

Contemporary Amperex Technology (03750): "26CATLK1" will be listed on the Shenzhen Stock Exchange starting from February 27th.